Abstract

Episodic ataxia type 1 and 2 (EA1 and EA2) are the most well-described of the episodic ataxias. They are autosomal dominantly inherited early-onset diseases characterized by attacks of cerebellar dysfunction. EA1 is clinically characterized by short episodes of ataxia with interictal myokymia, whereas EA2 is characterized by longer-lasting recurrent ataxia, slurred speech, and interictal nystagmus. We report on a patient with EA2 with interictal focal dystonia and also interictal myokymia, which is hitherto not reported as an interictal feature associated to EA2. The patient carries a previously described heterozygous pathogenic de novo frameshift variant in the CACNA1A gene, establishing the diagnosis of EA2. She had symptom onset at age 13 and from age 48 she developed interictal myokymia and focal dystonia as illustrated in Supplemental Movie S1. We conclude that interictal myokymia and focal dystonia may be interictal features associated to EA2 caused by the cerebellar pathophysiology of EA2. Episodes of ataxia were successfully treated with acetazolamide in low dose, whereas the interictal features were unresponsive to acetazolamide.

OriginalsprogEngelsk
Artikelnummera006236
TidsskriftCold Spring Harbor Molecular Case Studies
Vol/bind8
Udgave nummer6
ISSN2373-2873
DOI
StatusUdgivet - okt. 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Episodic ataxia type 2 (EA2) with interictal myokymia and focal dystonia'. Sammen danner de et unikt fingeraftryk.

Citationsformater